Cargando…

Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions

Background: The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs) as benefit metrics and their potential impact in de...

Descripción completa

Detalles Bibliográficos
Autores principales: Augustovski, Federico, Colantonio, Lisandro D., Galante, Julieta, Bardach, Ariel, Caporale, Joaquín E., Zárate, Víctor, Chuang, Ling Hsiang, Pichon-Riviere, Andres, Kind, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819372/
https://www.ncbi.nlm.nih.gov/pubmed/29524936
http://dx.doi.org/10.15171/ijhpm.2017.47
_version_ 1783301197040451584
author Augustovski, Federico
Colantonio, Lisandro D.
Galante, Julieta
Bardach, Ariel
Caporale, Joaquín E.
Zárate, Víctor
Chuang, Ling Hsiang
Pichon-Riviere, Andres
Kind, Paul
author_facet Augustovski, Federico
Colantonio, Lisandro D.
Galante, Julieta
Bardach, Ariel
Caporale, Joaquín E.
Zárate, Víctor
Chuang, Ling Hsiang
Pichon-Riviere, Andres
Kind, Paul
author_sort Augustovski, Federico
collection PubMed
description Background: The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs) as benefit metrics and their potential impact in decision-making. Methods: Two previously published models delivering outputs in QALYs, were adapted to estimate DALYs: a Markov model for human papilloma virus (HPV) vaccination, and a pneumococcal vaccination deterministic model (PNEUMO). Argentina, Chile, and the United Kingdom studies were used, where local EQ-5D social value weights were available to provide local QALY weights. A primary study with descriptive vignettes was done (n = 73) to obtain EQ-5D data for all health states included in both models. Several scenario analyses were carried-out to evaluate the relative importance of using different metrics (DALYS or QALYs) to estimate health benefits on these economic evaluations. Results: QALY gains were larger than DALYs avoided in all countries for HPV, leading to more favorable decisions using the former. With discounting and age-weighting – scenario with greatest differences in all countries – incremental DALYs avoided represented the 75%, 68%, and 43% of the QALYs gained in Argentina, Chile, and United Kingdom respectively. Differences using QALYs or DALYs were less consistent and sometimes in the opposite direction for PNEUMO. These differences, similar to other widely used assumptions, could directly influence decision-making using usual gross domestic products (GDPs) per capita per DALY or QALY thresholds. Conclusion: We did not find evidence that contradicts current practice of many researchers and decision-makers of using QALYs or DALYs interchangeably. Differences attributed to the choice of metric could influence final decisions, but similarly to other frequently used assumptions.
format Online
Article
Text
id pubmed-5819372
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-58193722018-02-23 Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions Augustovski, Federico Colantonio, Lisandro D. Galante, Julieta Bardach, Ariel Caporale, Joaquín E. Zárate, Víctor Chuang, Ling Hsiang Pichon-Riviere, Andres Kind, Paul Int J Health Policy Manag Original Article Background: The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs) as benefit metrics and their potential impact in decision-making. Methods: Two previously published models delivering outputs in QALYs, were adapted to estimate DALYs: a Markov model for human papilloma virus (HPV) vaccination, and a pneumococcal vaccination deterministic model (PNEUMO). Argentina, Chile, and the United Kingdom studies were used, where local EQ-5D social value weights were available to provide local QALY weights. A primary study with descriptive vignettes was done (n = 73) to obtain EQ-5D data for all health states included in both models. Several scenario analyses were carried-out to evaluate the relative importance of using different metrics (DALYS or QALYs) to estimate health benefits on these economic evaluations. Results: QALY gains were larger than DALYs avoided in all countries for HPV, leading to more favorable decisions using the former. With discounting and age-weighting – scenario with greatest differences in all countries – incremental DALYs avoided represented the 75%, 68%, and 43% of the QALYs gained in Argentina, Chile, and United Kingdom respectively. Differences using QALYs or DALYs were less consistent and sometimes in the opposite direction for PNEUMO. These differences, similar to other widely used assumptions, could directly influence decision-making using usual gross domestic products (GDPs) per capita per DALY or QALY thresholds. Conclusion: We did not find evidence that contradicts current practice of many researchers and decision-makers of using QALYs or DALYs interchangeably. Differences attributed to the choice of metric could influence final decisions, but similarly to other frequently used assumptions. Kerman University of Medical Sciences 2017-05-06 /pmc/articles/PMC5819372/ /pubmed/29524936 http://dx.doi.org/10.15171/ijhpm.2017.47 Text en © 2018 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Augustovski, Federico
Colantonio, Lisandro D.
Galante, Julieta
Bardach, Ariel
Caporale, Joaquín E.
Zárate, Víctor
Chuang, Ling Hsiang
Pichon-Riviere, Andres
Kind, Paul
Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
title Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
title_full Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
title_fullStr Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
title_full_unstemmed Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
title_short Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
title_sort measuring the benefits of healthcare: dalys and qalys – does the choice of measure matter? a case study of two preventive interventions
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819372/
https://www.ncbi.nlm.nih.gov/pubmed/29524936
http://dx.doi.org/10.15171/ijhpm.2017.47
work_keys_str_mv AT augustovskifederico measuringthebenefitsofhealthcaredalysandqalysdoesthechoiceofmeasurematteracasestudyoftwopreventiveinterventions
AT colantoniolisandrod measuringthebenefitsofhealthcaredalysandqalysdoesthechoiceofmeasurematteracasestudyoftwopreventiveinterventions
AT galantejulieta measuringthebenefitsofhealthcaredalysandqalysdoesthechoiceofmeasurematteracasestudyoftwopreventiveinterventions
AT bardachariel measuringthebenefitsofhealthcaredalysandqalysdoesthechoiceofmeasurematteracasestudyoftwopreventiveinterventions
AT caporalejoaquine measuringthebenefitsofhealthcaredalysandqalysdoesthechoiceofmeasurematteracasestudyoftwopreventiveinterventions
AT zaratevictor measuringthebenefitsofhealthcaredalysandqalysdoesthechoiceofmeasurematteracasestudyoftwopreventiveinterventions
AT chuanglinghsiang measuringthebenefitsofhealthcaredalysandqalysdoesthechoiceofmeasurematteracasestudyoftwopreventiveinterventions
AT pichonriviereandres measuringthebenefitsofhealthcaredalysandqalysdoesthechoiceofmeasurematteracasestudyoftwopreventiveinterventions
AT kindpaul measuringthebenefitsofhealthcaredalysandqalysdoesthechoiceofmeasurematteracasestudyoftwopreventiveinterventions